84 related articles for article (PubMed ID: 16343875)
1. Controlled release of saccharides from matrix tablets.
Mäki R; Suihko E; Korhonen O; Pitkänen H; Niemi R; Lehtonen M; Ketolainen J
Eur J Pharm Biopharm; 2006 Feb; 62(2):163-70. PubMed ID: 16343875
[TBL] [Abstract][Full Text] [Related]
2. Modifying drug release and tablet properties of starch acetate tablets by dry powder agglomeration.
Mäki R; Suihko E; Rost S; Heiskanen M; Murtomaa M; Lehto VP; Ketolainen J
J Pharm Sci; 2007 Feb; 96(2):438-47. PubMed ID: 17075868
[TBL] [Abstract][Full Text] [Related]
3. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets.
van Veen B; Pajander J; Zuurman K; Lappalainen R; Poso A; Frijlink HW; Ketolainen J
Eur J Pharm Biopharm; 2005 Oct; 61(3):149-57. PubMed ID: 16005196
[TBL] [Abstract][Full Text] [Related]
4. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
Ferrero C; Jiménez-Castellanos MR
Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
[TBL] [Abstract][Full Text] [Related]
5. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
Obeidat WM; Alzoubi NM
Pharmazie; 2014 Feb; 69(2):96-103. PubMed ID: 24640597
[TBL] [Abstract][Full Text] [Related]
6. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
7. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
Bravo SA; Lamas MC; Salamón CJ
J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888
[TBL] [Abstract][Full Text] [Related]
8. Starch acetate as a tablet matrix for sustained drug release.
Pohja S; Suihko E; Vidgren M; Paronen P; Ketolainen J
J Control Release; 2004 Feb; 94(2-3):293-302. PubMed ID: 14744481
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride.
Patra CN; Kumar AB; Pandit HK; Singh SP; Devi MV
Acta Pharm; 2007 Dec; 57(4):479-89. PubMed ID: 18165191
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of ethylcellulose as matrices for controlled release drug delivery.
Quadir MA; Chanda E; Haider SS; Reza MD; Datta BK
Pak J Pharm Sci; 2005 Apr; 18(2):29-34. PubMed ID: 16431395
[TBL] [Abstract][Full Text] [Related]
11. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
[TBL] [Abstract][Full Text] [Related]
12. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
13. Hydroxypropylated starches of varying amylose contents as sustained release matrices in tablets.
Onofre FO; Wang YJ
Int J Pharm; 2010 Jan; 385(1-2):104-12. PubMed ID: 19879935
[TBL] [Abstract][Full Text] [Related]
14. Effect of the molecular size of carboxymethylcellulose and some polymers on the sustained release of theophylline from a hydrophilic matrix.
Emeje MO; Kunle OO; Ofoefule SI
Acta Pharm; 2006 Sep; 56(3):325-35. PubMed ID: 19831281
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hydrophilic, hydrophobic and waxy matrix excipients for sustained release tablets of venlafaxine hydrochloride.
Yadav K; Yadav D; Srivastava AK
Drug Dev Ind Pharm; 2013 Aug; 39(8):1197-206. PubMed ID: 22803761
[TBL] [Abstract][Full Text] [Related]
16. Effect of formulation parameters and drug-polymer interactions on drug release from starch acetate matrix tablets.
Pajander J; Korhonen O; Laamanen M; Ryynänen EL; Grimsey I; van Veen B; Ketolainen J
J Pharm Sci; 2009 Oct; 98(10):3676-90. PubMed ID: 19177516
[TBL] [Abstract][Full Text] [Related]
17. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
Efentakis M; Naseef H; Vlachou M
Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
Fuertes I; Miranda A; Millán M; Caraballo I
Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
[TBL] [Abstract][Full Text] [Related]
19. Formulation design of double-layer in the outer shell of dry-coated tablet to modulate lag time and time-controlled dissolution function: studies on micronized ethylcellulose for dosage form design (VII).
Lin SY; Lin KH; Li MJ
AAPS J; 2004 Jul; 6(3):e17. PubMed ID: 15760102
[TBL] [Abstract][Full Text] [Related]
20. Formulation development of sustained-release hydrophilic matrix tablets of zileuton.
Qiu Y; Hui HW; Cheskin H
Pharm Dev Technol; 1997 Aug; 2(3):197-204. PubMed ID: 9552447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
